BSE filing, BSE: 543309. Summary written from the filing by ALFA Finder's alert engine.
Adeshwar Meditex Ltd: key numbers
- Share price
- ₹15.80
- Market cap
- ₹22.80 Cr
- Revenue (annual)
- ₹56.10 Cr
- Net profit (annual)
- ₹1.26 Cr
- P/E (TTM)
- 18.0×Sector 52.0×
- Promoter holding
- 57.68%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Adeshwar Meditex Ltd
All →Adeshwar Meditex Other Announcement
Adeshwar Meditex Ltd filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b). This is a routine periodic disclosure.
Adeshwar Meditex Management Change
Adeshwar Meditex Limited announced the appointment of Shankar Ramesh & Co. LLP as statutory auditor, alongside changes in its board of directors and auditor tenure completions.
Adeshwar Meditex Annual General Meeting
Adeshwar Meditex held its 19th AGM on 23 Sep 2026. Routine matters including adoption of financials and director appointments were transacted.
Adeshwar Meditex Other Announcement
Adeshwar Meditex Ltd has filed its quarterly shareholding pattern for the period ended March 31, 2026, as per regulatory requirements.
Adeshwar Meditex Annual General Meeting
Adeshwar Meditex Limited has filed its Annual Report for FY 2025-26 and the notice for its 19th Annual General Meeting to be held on September 23, 2026.
Adeshwar Meditex Annual Report
Adeshwar Meditex Limited has filed its Annual Report for the financial year 2025-26. The document provides comprehensive details on the company's annual operations and financial performance.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.